Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines
Daryl Tan(Singapore General Hospital), Yok‐Lam Kwong(Queen Mary Hospital), Soon Thye Lim(National University of Singapore), Ranjana H. Advani(Stanford Medicine), Won-Seog Kim(Samsung Medical Center), Soo‐Yong Tan(Monash Health), Seok Jin Kim(Samsung (South Korea))
Cited by 43
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
|Journal of Clinical Oncology|2012|1.1k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
|New England Journal of Medicine|2018|1.1k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719